النشاطات العلمية لفرع الفكر السياسي

0

The analysis of COVID-19 data in Iraq is carried out. Data includes daily cases and deaths since the outbreak of the pandemic in Iraq on February 2020 until the 28th of June 2022. This is done by fitting some distributions to the data in order to find out the most appropriate distribution fit to both daily cases and deaths due to the COVID-19 pandemic. The statistical analysis includes estimation of the parameters, the goodness of fit tests and illustrative probability plots. It was found that the generalized extreme value and the generalized Pareto distributions may provide a good fit for the data for both daily cases and deaths. However, they were rejected by the goodness of fit test statistics due to the high variability of the data.<

      Today, the world is living in a time of epidemic diseases that spread unnaturally and infect and kill millions of people worldwide. The COVID-19 virus, which is one of the most well-known epidemic diseases currently spreading, has killed more than six million people as of May 2022. The World Health Organization (WHO) declared the 2019 coronavirus disease (COVID-19) after an outbreak of SARS-CoV-2 infection. COVID-19 is a severe and potentially fatal respiratory disease caused by the SARS-CoV-2 virus, which was first noticed at the end of 2019 in Wuhan city. Artificial intelligence plays a meaningful role in analyzing medical images and giving accurate results that serve healthcare workers, especially X-ray images, which are co

The current research aims to identify the level of mental alertness among students of the Department of Chemistry in the Faculty of Education for Pure Sciences – Ibn Al-Haytham during the academic year (2022-2023). To achieve this goal, a descriptive approach was followed. The research community was identified as all chemistry students across the four grades (first, second, third, and fourth). A sample from each grade was selected for the current research. A tool was prepared to measure mental alertness within the research sample. The researcher adopted the scale by Baer, Smith, Kristemoyer, & Tany (2006), which was developed by Al-Buhairi et al. (2014), ensuring its validity, reliability, and psychometric characteristics, making i

The emergence of SARS-CoV-2, the virus responsible for the COVID-19 pandemic, has resulted in a global health crisis leading to widespread illness, death, and daily life disruptions. Having a vaccine for COVID-19 is crucial to controlling the spread of the virus which will help to end the pandemic and restore normalcy to society. Messenger RNA (mRNA) molecules vaccine has led the way as the swift vaccine candidate for COVID-19, but it faces key probable restrictions including spontaneous deterioration. To address mRNA degradation issues, Stanford University academics and the Eterna community sponsored a Kaggle competition.This study aims to build a deep learning (DL) model which will predict deterioration rates at each base of the mRNA

Abstract

Background: The novel coronavirus 2 (SARS?CoV?2) pandemic is a pulmonary disease, which leads to cardiac, hematologic, and renal complications. Anticoagulants are used for COVID-19 infected patients because the infection increases the risk of thrombosis. The world health organization (WHO), recommend prophylaxis dose of anticoagulants: (Enoxaparin or unfractionated Heparin for hospitalized patients with COVID-19 disease. This has created an urgent need to identify effective medications for COVID-19 prevention and treatment. The value of COVID-19 treatments is affected by cost-effectiveness analysis (CEA) to inform relative value and how to best maximize social welfare through eviden

Abstract Background: The novel coronavirus 2 (SARS?CoV?2) pandemic is a pulmonary disease, which leads to cardiac, hematologic, and renal complications. Anticoagulants are used for COVID-19 infected patients because the infection increases the risk of thrombosis. The world health organization (WHO), recommend prophylaxis dose of anticoagulants: (Enoxaparin or unfractionated Heparin for hospitalized patients with COVID-19 disease. This has created an urgent need to identify effective medications for COVID-19 prevention and treatment. The value of COVID-19 treatments is affected by cost-effectiveness analysis (CEA) to inform relative value and how to best maximize social welfare through evidence-based pricing decisions. O